We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Immunotherapy in Leprosy-Reply

Chapman H. Binford, MD; Wayne M. Meyers, MD, PhD; Gerald P. Walsh, PhD
JAMA. 1982;248(21):2833. doi:10.1001/jama.1982.03330210025011.
Text Size: A A A
Published online

In Reply.—  We appreciate Dr Fusaro's discussion of research on the use of transfer factor in efforts to enhance the immunity of lepromatous patients.Our article cited the work of Hastings and Job,1 who treated four lepromatous patients and one borderline patient with transfer factor obtained from approximately 7.4×109 lymphocytes given in 36 divided doses during 12 weeks.Clinical reversal reactions (immunologic upgrading) were observed in the four lepromatous patients but not in the borderline patient.2 Histopathologically, skin biopsy specimens of the four lepromatous patients showed a reduction of acid-fast bacilli and proliferation of epithelioid and giant cells.In one lepromatous patient, the reversal reaction persisted 14 months after the injections were stopped. In two lepromatous patients, they continued to appear four to 28 months after the last transfer factor injection was given. In the remaining lepromatous patient, the reversal reaction continued five months after the last injection,


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.